nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

20.06.2020 | Retinal Disorders

Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to determine the probability of progression of myopic maculopathy according to age.

Methods

This is a longitudinal observational study of single-center retrospective cohort of Caucasian patients formed by 212 consecutive adults with high myopia. Main outcome measures were age, visual acuity (VA), refractive error (RE), follow-up time, and the macular status assessed at least 5 years apart according to the Meta-Analysis of Pathologic Myopia Study Group. The progression rate was calculated based on per 1000 eyes/year. Multistate models were fitted to identify the predictive factors and to calculate the most probable age of progression onset using the Aalen–Johansen estimator.

Results

We studied 220 eyes of 122 Caucasian patients. Mean age was 48.18 ± 14.1, mean follow-up 12.73 ± 5.81 years. One-hundred and fifty-two (69.1%) eyes progressed of category, and 96 (44%) worsened a mean of 0.3 logMAR units during follow-up. The progression rate was 32.21/1000 eyes/year. The probability of progressing increased with age; it was higher in women if there was a family history of myopia, worse VA, higher RE, or wide macular staphyloma. The probability of progressing from category 1 was > 0.6 after 70 years of age; from category 2, it was 0.7 after 70 years; and 0.5 from category 3 after 75 years. If choroidal neovascularization (CNV) appeared, this probability exceeded 0.7 between ages 45 and 55 for all categories.

Conclusion

The progression rate is lower than in a Japanese series. The vision worsened with disease progression, and the probability of both happening increased after the age of 70–75. If CNV appears, the risk of progression is very high at the age of 45–55.

Ohno-Matsui K (2016) Pathologic myopia. Asia Pac J Ophthalmol (Phila) 5:415–423. https://doi.org/10.1097/APO.0000000000000230CrossRef

Curtin BJ (1977) The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc 75:67–86 PMID: 613534PubMedPubMedCentral

Ohno-Matsui K (2014) Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology 121:1798–1809. https://doi.org/10.1016/j.ophtha.2014.03.035CrossRefPubMed

Verkicharla PK, Ohno-Matsui K, Saw SM (2015) Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt 35:465–475. https://doi.org/10.1111/opo.12238CrossRefPubMed

Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, Yamazaki M, Meuer S, Ishibashi T, Yasuda M, Yamashita H, Sugano A, Wang JJ, Mitchell P, Wong TY, META-analysis for Pathologic Myopia (META-PM) Study Group (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159(877–883):e7. https://doi.org/10.1016/j.ajo.2015.01.022CrossRef

Fang Y, Yokoi T, Nagaoka N, Shinohara K, Onishi Y, Ishida T, Yoshida T, Xu X, Jonas JB, Ohno-Matsui K (2018) Progression of myopic maculopathy during 18-year follow-up. Ophthalmology 125:863–877. https://doi.org/10.1016/j.ophtha.2017.12.005CrossRefPubMed

Hashemi H, Fotouhi A, Yekta A, Pakzad R, Ostadimoghaddam H, Khabazkhoob M (2018) Global and regional estimates of prevalence of refractive errors: systematic review and meta-analysis. J Curr Ophthalmol 30:3–22. https://doi.org/10.1016/j.joco.2017.08.009CrossRefPubMed

Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123:1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006CrossRefPubMed

Grossniklaus HE, Green WR (1992) Pathologic findings in pathologic myopia. Retina 12:127–133. https://doi.org/10.1097/00006982-199212020-00009CrossRefPubMed

10.

Liu HH, Xu L, Wang YX, Wang S, You QS, Jonas JB (2010) Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study. Ophthalmology 117:1763–1768. https://doi.org/10.1016/j.ophtha.2010.01.020CrossRefPubMed

11.

Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, Yasuzumi K, Nagaoka N, Saka N, Yoshida T, Tokoro T, Mochizuki M (2010) Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology 117(1595–1611):e1–e4. https://doi.org/10.1016/j.ophtha.2009.11.003CrossRef

12.

Yan YN, Wang YX, Yang Y, Xu L, Xu J, Wang Q, Yang JY, Yang X, Zhou WJ, Ohno-Matsui K, Wei WB, Jonas JB (2018) Ten-year progression of myopic maculopathy: the Beijing Eye Study 2001–2011. Ophthalmology 125:1253–1263. https://doi.org/10.1016/j.ophtha.2018.01.035CrossRefPubMed

13.

Choudhury F, Meuer SM, Klein R, Wang D, Torres M, Jiang X, McKean-Cowdin, Varma R, Chinese American Eye Study Group (2018) Prevalence and characteristics of myopic degeneration in an adult Chinese American population: the Chinese American Eye Study. Am J Ophthalmol 187:34–42. https://doi.org/10.1016/j.ajo.2017.12.010CrossRefPubMed

14.

Cumberland PM, Bountziouka V, Rahi JS (2018) Impact of varying the definition of myopia on estimates of prevalence and associations with risk factors: time for an approach that serves research, practice and policy. Br J Ophthalmol 102:1407–1412. https://doi.org/10.1136/bjophthalmol-2017-311557CrossRefPubMedPubMedCentral

15.

Schmoor C, Schumacher M, Finke J, Beyersmann J (2013) Competing risks and multistate models. Clin Cancer Res 19:12–21CrossRef

16.

Kumar A, Chawla R, Kumawat D, Pillay G (2017) Insight into high myopia and the macula. Indian J Ophthalmol 65:85–91. https://doi.org/10.4103/ijo.IJO_863_16CrossRefPubMedPubMedCentral

17.

Jabs DA (2005) Improving the reporting of clinical case series. Am J Ophthalmol 139:900–905. https://doi.org/10.1016/j.ajo.2004.12.009CrossRefPubMed

18.

Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc Ser B 34:187–220 https://www.jstor.org/stable/2985181

19.

Aalen OO, Johansen S (1978) An empirical transition matrix for nonhomogeneous Markov chains based on censored observations. Scand J Stat 5:141–150 https://www.jstor.org/stable/4615704

20.

Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526. https://doi.org/10.1093/biomet/81.3.515CrossRef

21.

Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80–115. https://doi.org/10.1016/j.preteyeres.2018.10.005CrossRefPubMed

22.

Vongphanit J, Mitchell P, Wang JJ (2002) Prevalence and progression of myopic retinopathy in an older population. Ophthalmology 109:70411. https://doi.org/10.1016/s0161-6420(01)01024-7CrossRef

23.

Gozum N, Cakir M, Gucukoglu A, Sezen F (1997) Relationship between retinal lesions and axial length, age and sex in high myopia. Eur J Ophthalmol 7:277–282CrossRef

24.

Shih YF, Ho TC, Hsiao CK, Lin LL (2006) Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol 90:546–550. https://doi.org/10.1136/bjo.2005.081992CrossRefPubMedPubMedCentral

25.

Ohno-Matsui K, Alkabes M, Salinas C, Mateo C, Moriyama M, Cao K, Yoshida T (2017) Features of posterior staphylomas analyzed in wide-field fundus images in patients with unilateral and bilateral pathologic myopia. Retina 37:477–486. https://doi.org/10.1097/IAE.0000000000001327CrossRefPubMed

26.

Chang L, Pan CW, Ohno-Matsui K, Cheung GC, Gazzard G, Koh V, Hamzah H, Tai ES, Lim SC, Mitchell P, Young TL, Aung T, Wong TY, Saw SM (2013) Myopia-related fundus changes in Singapore adults with high myopia. Am J Ophthalmol 155(991–999):e1. https://doi.org/10.1016/j.ajo.2013.01.016CrossRef

27.

Jonas JB, Fang Y, Weber P, Ohno-Matsui K (2018) Parapapillary gamma and delta zones in high myopia. Retina 38:931–938. https://doi.org/10.1097/IAE.0000000000001650CrossRefPubMed

28.

Liang CL, Yen E, Su JY, Liu C, Chang TY, Park N, Wu MJ, Lee S, Flynn JT, Juo SH (2004) Impact of family history of high myopia on level and onset of myopia. Invest Ophthalmol Vis Sci 45:3446–3452. https://doi.org/10.1167/iovs.03-1058CrossRefPubMed

29.

Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581. https://doi.org/10.1016/s0161-6420(84)34116-1CrossRefPubMed

30.

Farinha CL, Baltar AS, Nunes SG, Figueira JP, Pires IA, Cachulo ML, Silva RM (2014) Progression of myopic maculopathy after treatment of choroidal neovascularization. Ophthalmologica 231:211–220. https://doi.org/10.1159/000357290CrossRefPubMed

31.

Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH (2019) Trends in the prevalence of myopia and myopic Maculopathy in a Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 60:2781–2786. https://doi.org/10.1167/iovs.19-26580CrossRefPubMed

32.

Ito-Ohara M, Seko Y, Morita H, Imagawa N, Tokoro T (1998) Clinical course of newly developed or progressive patchy chorioretinal atrophy in pathological myopia. Ophthalmologica 212:23–29. https://doi.org/10.1159/000027254CrossRefPubMed

33.

Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A, Tokoro T, Mochizuki M (2003) Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 87:570–573. https://doi.org/10.1136/bjo.87.5.570CrossRefPubMedPubMedCentral

Titel: Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis
Publikationsdatum: 20.06.2020
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2021
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-020-04795-5

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Progression of myopic maculopathy in a Caucasian cohort of highly myopic patients with long follow-up: a multistate analysis

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Association of lateral rectus muscle volume and ocular motility with the abducens nerve in Duane’s retraction syndrome

Ocular fixation and macular integrity by microperimetry in multiple sclerosis

Correction to: Benchmarking different brands of silicone oils

Evaluation of 20-MHz high-frequency ultrasonography for the diagnosis of choroidal nevi

Atopic dermatitis as a risk factor for severe visual field loss in youth—a retrospective cohort study of glaucoma under steroid treatment

Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco) versus PPV and deferred phaco for phakic patients with full-thickness macular hole (FTMH) and no significant cataract at baseline: 1-year outcomes of a randomized trial combined PPV/phaco vs PPV/deferred phaco for MH

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde